M Decramer, V de Bock and R Dom
Respiratory Muscle Research Unit, Laboratory of Pneumology, Katholieke Universiteit Leuven, Belgium.

The functional and histologic picture of steroid-induced myopathy was systematically examined in eight patients with chronic obstructive pulmonary disease (COPD) and compared with control patients with COPD matched for age, sex, and degree of airflow obstruction. Steroid- induced myopathy was associated with severe peripheral muscle weakness, quadriceps force being 23 +/- 14 versus 71 +/- 23% in control patients with COPD (p < 0.001). In addition, clear ventilatory muscle weakness was present. PImax was 37 +/- 15 versus 67 +/- 24% in control patients (p < 0.001 ), and PEmax averaged 34 +/- 10 versus 74 +/- 23% (p < 0.001). Vital capacity tended to be slightly reduced compared with that in control patients (69 +/- 21 versus 80 +/- 16%, p = 0.11). The only biochemical abnormalities associated to steroid-induced myopathy were a moderately increased lactic dehydrogenase level (697 +/- 301 versus 421 +/- 128 IU/L, p < 0.001) and an increased creatine excretion in 24-h urine (990 +/- 609 versus 159 +/- 219 mg/24 h, p< 0.001). On quadriceps biopsy steroid-induced myopathy was characterized by increased variation in diameter of fibers, with several angular atrophic fibers and diffuse necrotic and basophilic fibers. In addition, increased amount of connective tissue in between fibers and increased number of subsarcolemmal and central nuclei were present. On ATPase stain diffuse fiber atrophy predominantly affecting fast fibers was present, but there was no indication that atrophy was confined to type IIb fibers in contrast to conventional thinking. On follow-up, survival of patients with steroid-induced myopathy was reduced in comparison with control patients with COPD with similar degree of airflow obstruction (p < 0.025).

This article has been cited by other articles:

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				M. I. Lewis, M. Fournier, T. W. Storer, S. Bhasin, J. Porszasz, S.-G. Ren, X. Da, and R. Casaburi Skeletal muscle adaptations to testosterone and resistance training in men with COPD J Appl Physiol, October 1, 2007; 103(4): 1299 - 1310. [Abstract] [Full Text] [PDF]

				K. F. Rabe, S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 532 - 555. [Abstract] [Full Text] [PDF]

				M. Van Vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van Herck, F. Pitta, R. Bouillon, and M. Decramer Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1105 - 1111. [Abstract] [Full Text] [PDF]

				A. Couillard and C. Prefaut From muscle disuse to myopathy in COPD: potential contribution of oxidative stress Eur. Respir. J., October 1, 2005; 26(4): 703 - 719. [Abstract] [Full Text] [PDF]

				M. A Spruit Enhanced physiotherapy management of acute exacerbations of chronic obstructive pulmonary disease Chronic Respiratory Disease, July 1, 2005; 2(3): 117 - 119. [PDF]

				T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38. [Full Text] [PDF]

				J. P Mattson and J. C Martin Emphysema-induced reductions in locomotory skeletal muscle contractile function Exp Physiol, July 1, 2005; 90(4): 519 - 525. [Abstract] [Full Text] [PDF]

				T. J Ringbaek and P. Lange Outdoor activity and performance status as predictors of survival in hypoxaemic chronic obstructive pulmonary disease (COPD) Clinical Rehabilitation, March 1, 2005; 19(3): 331 - 338. [Abstract] [PDF]

				M A Spruit, M J Thomeer, R Gosselink, T Troosters, A Kasran, A J T Debrock, M G Demedts, and M Decramer Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status Thorax, January 1, 2005; 60(1): 32 - 38. [Abstract] [Full Text] [PDF]

				S. Mathur, W D. Reid, and R. D Levy Exercise Limitation in Recipients of Lung Transplants Physical Therapy, December 1, 2004; 84(12): 1178 - 1187. [Full Text] [PDF]

				R. Casaburi, S. Bhasin, L. Cosentino, J. Porszasz, A. Somfay, M. I. Lewis, M. Fournier, and T. W. Storer Effects of Testosterone and Resistance Training in Men with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 870 - 878. [Abstract] [Full Text] [PDF]

				C Pinet, P Scillia, M Cassart, M Lamotte, C Knoop, C Melot, and M Estenne Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis Thorax, September 1, 2004; 59(9): 783 - 789. [Abstract] [Full Text] [PDF]

				B Polla, G D'Antona, R Bottinelli, and C Reggiani Respiratory muscle fibres: specialisation and plasticity Thorax, September 1, 2004; 59(9): 808 - 817. [Abstract] [Full Text] [PDF]

				N.S. Hopkinson, W.D-C. Man, M.J. Dayer, E.T. Ross, A.H. Nickol, N. Hart, J. Moxham, and M.I. Polkey Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease Eur. Respir. J., July 1, 2004; 24(1): 137 - 142. [Abstract] [Full Text] [PDF]

				T J Ringbaekl, K Viskuml, and P Lange BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long-term oxygen therapy Chronic Respiratory Disease, April 1, 2004; 1(2): 71 - 78. [Abstract] [PDF]

				L. F. De Swert, C. Wouters, and F. de Zegher Myopathy in Children Receiving High-Dose Inhaled Fluticasone N. Engl. J. Med., March 11, 2004; 350(11): 1157 - 1159. [Full Text] [PDF]

				M. Orozco-Levi Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? Eur. Respir. J., November 2, 2003; 22(46_suppl): 41S - 51s. [Abstract] [Full Text] [PDF]

				M I Polkey Peripheral muscle weakness in COPD: where does it come from? Thorax, September 1, 2003; 58(9): 741 - 742. [Full Text] [PDF]

				M A Spruit, R Gosselink, T Troosters, A Kasran, G Gayan-Ramirez, P Bogaerts, R Bouillon, and M Decramer Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I Thorax, September 1, 2003; 58(9): 752 - 756. [Abstract] [Full Text] [PDF]

				H.R. Gosker, B. Kubat, G. Schaart, G.J. van der Vusse, E.F.M. Wouters, and A.M.W.J. Schols Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease Eur. Respir. J., August 1, 2003; 22(2): 280 - 285. [Abstract] [Full Text] [PDF]

				F. Laghi and M. J. Tobin Disorders of the Respiratory Muscles Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48. [Abstract] [Full Text] [PDF]

				M. Fournier, Z.-S. Huang, H. Li, X. Da, B. Cercek, and M. I. Lewis Insulin-like growth factor I prevents corticosteroid-induced diaphragm muscle atrophy in emphysematous hamsters Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R34 - R43. [Abstract] [Full Text] [PDF]

				D. J. Bihari, F. S.S. Leijten, M. A. Spruit, B. Nemery, M. Decramer, M. S. Herridge, and the Toronto ARDS Outcomes Group Survivors of the Acute Respiratory Distress Syndrome N. Engl. J. Med., May 22, 2003; 348(21): 2149 - 2150. [Full Text] [PDF]

				F. Ribera, B. N'Guessan, J. Zoll, D. Fortin, B. Serrurier, B. Mettauer, X. Bigard, R. Ventura-Clapier, and E. Lampert Mitochondrial Electron Transport Chain Function Is Enhanced in Inspiratory Muscles of Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 873 - 879. [Abstract] [Full Text] [PDF]

				A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets Systemic effects of chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2003; 21(2): 347 - 360. [Abstract] [Full Text] [PDF]

				A. G. N. Agusti, J. Sauleda, C. Miralles, C. Gomez, B. Togores, E. Sala, S. Batle, and X. Busquets Skeletal Muscle Apoptosis and Weight Loss in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 485 - 489. [Abstract] [Full Text] [PDF]

				S. Nava, C. Fracchia, G. Callegari, N. Ambrosino, N. Barbarito, and G. Felicetti Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection Eur. Respir. J., August 1, 2002; 20(2): 497 - 499. [Abstract] [Full Text] [PDF]

				H. R Gosker, M. P. Engelen, H. van Mameren, P. J van Dijk, G. J van der Vusse, E. F. Wouters, and A. M. Schols Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease Am. J. Clinical Nutrition, July 1, 2002; 76(1): 113 - 119. [Abstract] [Full Text] [PDF]

				C. Haccoun, A. A. Smountas, W. J. Gibbons, J. Bourbeau, and L. C. Lands Isokinetic Muscle Function in COPD* Chest, April 1, 2002; 121(4): 1079 - 1084. [Abstract] [Full Text] [PDF]

				A.M.W.J. Schols, G. Wesseling, A.D.M. Kester, G. de Vries, R. Mostert, J. Slangen, and E.F.M. Wouters Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids Eur. Respir. J., March 1, 2001; 17(3): 337 - 342. [Abstract] [Full Text] [PDF]

				H. F. KIWULL-SCHÖNE, L. J. TEPPEMA, and P. J. KIWULL Low-dose Acetazolamide Does Affect Respiratory Muscle Function in Spontaneously Breathing Anesthetized Rabbits Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 478 - 483. [Abstract] [Full Text]

				H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1033 - 1047. [Abstract] [Full Text] [PDF]

				P. M. A. Calverley COPD : Early Detection and Intervention Chest, May 1, 2000; 117(5_suppl_2): 365S - 371S. [Abstract] [Full Text] [PDF]

				R. Casaburi Skeletal Muscle Function in COPD Chest, May 1, 2000; 117(5_suppl_1): 267S - 271S. [Abstract] [Full Text] [PDF]

				M. P. Engelen, A. M. Schols, J. D Does, and E. F. Wouters Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease Am. J. Clinical Nutrition, March 1, 2000; 71(3): 733 - 738. [Abstract] [Full Text] [PDF]

				J. G. PANTOJA, F. H. ANDRADE, A. E. FROST, W. L. ESCHENBACHER, and M. B. REID Respiratory and Limb Muscle Function in Lung Allograft Recipients Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1205 - 1211. [Abstract] [Full Text]

				Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease . A Statement of the American Thoracic Society and European Respiratory Society Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): S2 - 40. [Full Text] [PDF]

				P M A CALVERLEY Re-assessing the evidence about inhaled corticosteroids in chronic obstructive pulmonary disease Thorax, January 1, 1999; 54(1): 3 - 4. [Full Text]

				G. STASSIJNS, G. GAYAN-RAMIREZ, P. DE LEYN, G. VERHOEVEN, P. HERIJGERS, V. de BOCK, R. DOM, R. LYSENS, and M. DECRAMER Systolic Ventricular Dysfunction Causes Selective Diaphragm Atrophy in Rats Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1963 - 1967. [Abstract] [Full Text] [PDF]

				R. H. H. Van Balkom, P. N. R. Dekhuijzen, H. T. M. Folgering, J. H. Veerkamp, H. T. Van Moerkerk, J. A. M. Fransen, and C. L. A. Van Herwaarden Anabolic steroids in part reverse glucocorticoid-induced alterations in rat diaphragm J Appl Physiol, May 1, 1998; 84(5): 1492 - 1499. [Abstract] [Full Text] [PDF]